Zituvimet (sitagliptin / metformin) is a combination medication that's used to manage blood sugar in adults living with Type 2 diabetes. This medication is used in addition to a balanced diet and exercise. Zituvimet (sitagliptin / metformin) is taken by mouth twice a day with meals. Diarrhea, upper respiratory tract infection, and headache are some potential side effects.
Zituvimet (sitagliptin / metformin) is a combination of two different diabetes medications.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Yes, you should take each dose of Zituvimet (sitagliptin / metformin) with a meal. This can help lower your risk of having an upset stomach.
No. Don't break, cut, or chew Zituvimet (sitagliptin / metformin) tablets. It has a special coating that shouldn't be broken. Contact your prescriber if you're having trouble swallowing Zituvimet (sitagliptin / metformin). Your prescriber can talk with you about your options or alternative medications that might be easier for you to take.
Zituvimet (sitagliptin / metformin) isn't FDA-approved for weight loss. But some people who took a combination of sitagliptin and metformin during clinical studies noticed some weight loss. The amount of weight loss that people who took the combination had was similar to that of people who took metformin alone. So weight loss might be the results from having a nutritious diet and exercise plan that's recommended with this medication. Also keep in mind that everyone can have different experiences with Zituvimet (sitagliptin / metformin). Discuss with your primary care provider about weight management.
There isn't enough information to know whether Zituvimet (sitagliptin / metformin) is safe during pregnancy. But researchers do know that poorly controlled diabetes (e.g., high blood sugar) can lead to risks to the pregnancy. Talk to your healthcare team about the safest options to treat your diabetes during pregnancy.
Zituvimet and Janumet are two brand-name medications that both combine metformin and sitagliptin into one pill. These two brand-name medications are made by different pharmaceutical companies: Janumet is made by Merck, and Zituvimet is made by Zydus Lifesciences. Both medications are used to treat Type 2 diabetes in adults.
Zituvimet (sitagliptin / metformin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Zituvimet (sitagliptin / metformin) contains metformin, a medication that can rarely cause a condition called lactic acidosis (too much lactic acid in the blood). This condition can lead to other health problems that can be life-threatening. Let your prescriber know about any health conditions you have and the other medications you take before you start Zituvimet (sitagliptin / metformin). They can check your risk for lactic acidosis.
Tell your care team right away if you notice that you're breathing fast or short of breath or if you have irregular heartbeat, very upset stomach, or muscle pain. Also contact your care team if you feel very sleepy, tired, weak, dizzy, or cold. These can be signs that you have too much lactic acid in your blood.
Although rare, some people who took Zituvimet (sitagliptin / metformin) developed inflammation in their pancreas (pancreatitis). It's not clear whether people who already have problems with their pancreas are at higher risk during treatment. Stop Zituvimet (sitagliptin / metformin) and get medical help if you notice symptoms of having an inflamed pancreas, such as belly pain that won't go away or that spreads to your back, nausea, and vomiting.
Some clinical studies suggest that there might be a link between treatment with a DPP-4 inhibitor (like sitagliptin) and heart failure. Since Zituvimet (sitagliptin / metformin) contains a DPP-4 inhibitor, it's important to be aware of the risk for heart failure. Make sure to let your care team know about your full medical history before you start this medication, especially if you have a history of heart failure. Contact your care team right away if you notice any symptoms related to heart failure, like shortness of breath, rapid or irregular heartbeat, swelling in ankles or feet, sudden weight gain, and chest pain.
There have been some reports of worsening kidney function, such as acute (sudden) kidney failure, that sometimes required dialysis during treatment with Zituvimet (sitagliptin / metformin). This medication might not be the best option if you have kidney issues, so be sure to tell your primary care provider about your full medical history. Older adults might be at greater risk for sudden kidney problems. Your care team will check your blood work at least once a year to check your kidney function while you're taking this medication.
Zituvimet (sitagliptin / metformin) can lower how much vitamin B12 your body absorbs and drop your vitamin B12 levels. This can lead to anemia. Let your healthcare team know if you've had any low energy, muscle weakness, low appetite, or tingling or numbness on hands or feet that doesn't seem to go away. You might need to get blood tests done to check for vitamin B12 deficiency and related anemia. Your primary care provider might order these blood tests periodically (every 1 to 3 years) during treatment with Zituvimet (sitagliptin / metformin).
You're at risk of having low blood sugar if you take Zituvimet (sitagliptin / metformin) together with other diabetes medications, particularly insulin or a sulfonylurea. Very low blood sugar can be life-threatening. Symptoms of low blood sugar include feeling shaky, very hungry, confused, or weak; being nervous or anxious; having a fast heartbeat; or sweating. It's important to know how to recognize and treat low blood sugar. Talk to your healthcare team if you're concerned about having low blood sugar levels.
Some people who've taken medications containing a DPP-4 inhibitor like the sitagliptin in Zituvimet have reported severe and disabling joint pain. This joint pain can occur anytime after starting this medication, from one day to years. Talk to a healthcare professional if you have any discomfort in your joints.
Some people who took a DPP-4 inhibitor medication like the sitagliptin in Zituvimet have had an itchy, blistering rash called bullous pemphigoid. The blisters or sores usually go away with appropriate treatment and once you stop taking Zituvimet (sitagliptin / metformin). Stop taking this medication and speak to your care team right away if you have itchy skin, rash with blisters, or sores.
Severe allergic reactions to Zituvimet (sitagliptin / metformin) are rare but possible. Though allergic reactions can happen at any time during treatment, people have reported a reaction within the first 3 months of starting the medication. Get medical help right away if you experience hives, blisters, peeling skin, trouble breathing, or swelling in your face or throat.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 50mg/500mg | 30 tablets | $108.70 | $3.62 |
| 50mg/1000mg | 180 tablets | $520.14 | $2.89 |
The typical starting dose is 50 mg/500 mg (sitagliptin/metformin) by mouth twice a day with meals.
Your dose might differ if you were taking metformin by itself before you started Zituvimet.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Zituvimet (sitagliptin / metformin) will not be safe for you to take.